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As understood, the AF group had higher rates of CHA 2 DS 2-VASc score 4 than the non-AF group ( Table 2 in the article  1 ) , while there were no significant differences in rate of subtypes of AF within groups regarding the presence of NR (Table 4 in  the article  1 ) . We would like to see comparison of rates of overall AF and CHA 2 DS 2 VASc score within these groups in Table 4 in the article. 1 These findings suggested CHA 2 DS 2-VASc score 4 as an important lack in logistic regression analysis ( Table 3 in the article  1 ) . Several studies [2] [3] [4] indicated the importance of CHA 2 DS 2-VASc score in cardiovascular mortality and morbidity, independently from the presence of AF. Kim et al 2 suggested that the CHA 2 DS 2 VASc score can be used to stratify the prognosis of patients with acute myocardial infarction (AMI), irrespective of the presence of AF. Patients with AMI with higher CHA 2 DS 2 VASc score had worse cardiovascular outcome. Kılıc et al 3 reported that the CHA 2 DS 2 VASc score could be considered as a predictor of risk of failed reperfusion after thrombolytic therapy in patients with STEMI. As mentioned in the text, Tanık et al 4 determined that CHA 2 DS 2 VASc scores 4 were independently associated with acute stent thrombosis in patients with STEMI treated with primary percutaneous intervention. They excluded patients with AF on admission and those who developed AF during the course of their hospital stay.
The authors 1 concluded that coronary microvascular dysfunction (CMD) plays a key role in NR. Coronary microvascular dysfunction was defined as impairment of resting and stimulated blood flow to the myocardium in the presence of patent epicardial arteries. 5 Previous studies 6, 7 demonstrated that the most common conventional risk factors including hypertension and diabetes mellitus for coronary artery disease could contribute to NR as well since they all negatively alter CMD. As known, CHA 2 DS 2 VASc scores include both of these most conventional risk factors.
Consequently, the CHA 2 DS 2 VASc score is also one of the major findings of this study, but further well-structured studies are needed to confirm this association between NR and CHA 2 DS 2 VASc score in patients with STEMI.
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